APA (7th ed.) Citation

JK, C., RT, K., S, D., SJ, M., RN, E., R, B., . . . P, M. (2024). SON-1010: An albumin-binding IL-12 fusion protein that improves cytokine half-life, targets tumors, and enhances therapeutic efficacy. Frontiers in immunology, 15, 1493257. https://doi.org/10.3389/fimmu.2024.1493257

Chicago Style (17th ed.) Citation

JK, Cini, et al. "SON-1010: An Albumin-binding IL-12 Fusion Protein That Improves Cytokine Half-life, Targets Tumors, and Enhances Therapeutic Efficacy." Frontiers in Immunology 15 (2024): 1493257. https://doi.org/10.3389/fimmu.2024.1493257.

MLA (9th ed.) Citation

JK, Cini, et al. "SON-1010: An Albumin-binding IL-12 Fusion Protein That Improves Cytokine Half-life, Targets Tumors, and Enhances Therapeutic Efficacy." Frontiers in Immunology, vol. 15, 2024, p. 1493257, https://doi.org/10.3389/fimmu.2024.1493257.